A mouse model was used to determine the personalized treatment for a cancer patient

by Hospital Universitari de Bellvitge

4 years ago
ICO, IDIBELL, personalized oncology, sarcoma, cancer

A team from IDIBELL and ICO, using a mouse orthotopic model, conducted a real-time personalized oncology study to test the best therapeutic option to treat a type of relapse sarcoma.

La fruta y el cacao son la principal fuente de flavonoides en la alimentación infantil

by Universitat de Barcelona

4 years ago
IDIBELL, alimentación infantil, flavonoides, fruta, cacao

Maria Izquierdo, catedrática de Nutrición y Bromatología de la Universidad de Barcelona, y Raúl Zamora, experto del Instituto de Investigaciones Biomédicas de Bellvitge (IDIBELL), han realizado u...

Identification of a new biomarker for chromosomic instability thanks to the study of lysosomal function during cell division

by Universitat de Barcelona

4 years ago
IDIBELL, chromosomes, biomarker, lysosomal

Alterations in the separation of chromosomes during cell division (mitosis) cause a morphology in the cell nucleus that could help researchers identify the cells that show chromosomic instability. Thi...

IDIBELL and Dexeus Mujer will study embryonic development through human embryo genome edition

by Hospital Universitari de Bellvitge

4 years ago
Idibell, Dexeus, genetic edition, embryos, assisted reproduction

The team of Dra. Anna Veiga, who leads the study, will optimize the CRISPR/Cas9 technique to modify the human embryo genome

Avatar worms help to identify factors that modify genetic diseases

by Hospital Universitari de Bellvitge

4 years ago
IDIBELL, gene-editing technology in C, retinitis pigmentaria, drug treatments, genetic mutation, vision loss, retina, genetic diseases

IDIBELL researchers have used gene-editing technology in C. elegans to reproduce human mutations that cause retinitis pigmentaria. With this method, they have studied factors that affect disease devel...

Three IDIBELL researchers receive funding from the EU H2020 program

by Hospital Universitari de Bellvitge

4 years ago
IDIBELL, funding, H2020 program, PRIME, RISCC, 4-IN THE LUNG RUN

Three IDIBELL researchers have received funding from the European Union to develop research projects within the framework of the Work Program on Health of Social Challenges, in the context of the Hori...

An IDIBELL and UB research team demonstrates the involvement of glucose in the growth of tumor cells

by Hospital Universitari de Bellvitge

4 years ago
IDIBELL, UB, glucose, cancer, enzymes, mTOR

Researchers has demonstrated how is it connected molecularly the availability of nutrients and oncogenic signals

IDIBELL and Alba Pérez Foundation take a new step forward to develop a treatment for Ewing's sarcoma

by Hospital Universitari de Bellvitge

4 years ago
Alba Pérez Foundation, IDIBELL, Ewing's sarcoma

The Alba Pérez Foundation has signed a framework collaboration agreement with the Bellvitge Biomedical Research Institute that aims to support research projects related to Ewing's sarcoma, an investi...

Investigadores del ICO y del IDIBELL estudian el riesgo de los falsos positivos en el cribado de colon durante el período 2000-2017

by ICO - Institut Català d'Oncologia

4 years ago
ICO, IDIBELL, cáncer de colon, falso positivo

Los programas de cribado permiten detectar la enfermedad cuando se encuentra en estadios iniciales para tratarla a tiempo y aumentar las posibilidades de cura. A pesar de sus beneficios puede haber un...

IDIBELL and Pharmacelera sign a research agreement to find new drugs with anticancer applications

by Hospital Universitari de Bellvitge

4 years ago
IDIBELL, Pharmacelera, drugs, cancer, cohesin

Researchers at Bellvitge Biomedical Research Institute will develop a research project with the company Pharmacelera to look for new molecules that block the cohesin complex, with applications in seve...

Investigadores de la Universidad de Barcelona y del IDIBELL describen un nuevo tratamiento que podría hacer frente a dos enfermedades óseas

by Universitat de Barcelona

5 years ago
IDIBELL, osificación heterotópica, enfermedades óseas

El nuevo trabajo podría contribuir a mejorar el tratamiento de pacientes afectados por la osificación heterotópica o por la fibrodisplasia osificante progresiva.

Defective glial cells can push neurons toward Parkinson's disease

by IBEC - Institut de Bioenginyeria de Catalunya

5 years ago
IDIBELL, University of Barcelona, Parkinson's, glial cells, genetic, neuronal degeneration

A team of scientists led by Prof. Antonella Consiglio from the IDIBELL and the University of Barcelona (UB), and Prof. Angel Raya from the Center of Regenerative Medicine of Barcelona (CMR[B]/IDIBELL)...